glp-1 type 2 diabetes GLP-1-based therapies for diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome How GLP-1 Medicines Help Manage

This breadth of activity is unusual for a peptide of this size and has been the subject of extensive preclinical research

Infertility is a disease of the male or female reproductive system and is of increasing incidence in almost all countries of the world, regardless of ethnicity (1)

Safety, Sourcing, and Why Medical Oversight Is Non-Negotiable BPC-157 has a strong safety record in animal studies notably, the lethal dose (LD1) has not been achieved across decades of preclinical research, and it has been used in human ulcerative colitis and multiple sclerosis trials without reported toxicity.6 But the absence of adverse events in animals does not translate directly to human safety, particularly at unregulated doses from unverified sources

Together, they aim to create what the company calls dual activation and dual amplification of GLP-1 at the cellular level